Cervical cancer swabs. Photos: Courtesy Becton, Dickinson and Company
The first self-collection kits for cervical cancer screening were shipped to doctor's offices and other health care facilities today, Axios has learned, providing patients with an alternative to Pap smears.
Why it matters: The less-invasive self-swabs allow health clinics that don't have speculums, stirrups, and other equipment to start offering screening.
It's an alternative to Pap smears, which can cause extreme discomfort, including for those patients with a history of sexual trauma or chronic pain.
The big picture: About a quarter of U.S. women are overdue for cervical cancer screening, according to the National Cancer Institute. Women in the South, where screening and preventive care lag behind the rest of the country, are more likely to die from the treatable disease.
State of play: The Food and Drug Administration approved the test from BD(Becton, Dickinson and Company), along with a version by Roche, in May. Roche's test will be available later this fall, the New York Times reported last month.
Australia, Denmark, the Netherlands, and Sweden already use self-collected cervical cancer swabs.
How it works: The new test allows patients to collect their own sample of cells from vaginal walls while at a doctor's office, much like they'd take their own urine sample, said Jeff Andrews, vice president of global medical affairs for diagnostic solutions at BD.
